Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 3:38 pm Purchase | 2023-12-31 | 13G | Hepion Pharmaceuticals, Inc. HEPA | Armistice Capital, LLC | 8,360 8.670% | 8,360 (New Position) | Filing History |
| 2024-02-14 3:38 pm Purchase | 2023-12-31 | 13G | GeoVax Labs, Inc. GOVX | Armistice Capital, LLC | 3,111,069 9.990% | 3,111,069 (New Position) | Filing History |
| 2024-02-14 3:37 pm Purchase | 2023-12-31 | 13G | Greenlane Holdings, Inc. GNLN | Armistice Capital, LLC | 46 9.990% | 46 (New Position) | Filing History |
| 2024-02-14 3:37 pm Purchase | 2023-12-31 | 13G | FibroGen, Inc. FGEN | Armistice Capital, LLC | 390,560 9.930% | 390,560 (New Position) | Filing History |
| 2024-02-14 3:36 pm Purchase | 2023-12-31 | 13G | Eyenovia, Inc. EYEN | Armistice Capital, LLC | 54,725 9.700% | 54,725 (New Position) | Filing History |
| 2024-02-14 3:36 pm Purchase | 2023-12-31 | 13G | Erasca, Inc. ERAS | Armistice Capital, LLC | 8,096,000 5.360% | 8,096,000 (New Position) | Filing History |
| 2024-02-14 3:36 pm Purchase | 2023-12-31 | 13G | Enveric Biosciences, Inc. ENVB | Armistice Capital, LLC | 101 9.990% | 101 (New Position) | Filing History |
| 2024-02-14 3:35 pm Purchase | 2023-12-31 | 13G | Eledon Pharmaceuticals, Inc. ELDN | Armistice Capital, LLC | 2,442,742 9.990% | 2,442,742 (New Position) | Filing History |
| 2024-02-14 3:35 pm Purchase | 2023-12-31 | 13G | Dermata Therapeutics, Inc. DRMA | Armistice Capital, LLC | 2,747 9.990% | 2,747 (New Position) | Filing History |
| 2024-02-14 3:34 pm Purchase | 2023-12-31 | 13G | Draganfly Inc. DPRO | Armistice Capital, LLC | 197,559 9.990% | 197,559 (New Position) | Filing History |
| 2024-02-14 3:34 pm Purchase | 2023-12-31 | 13G | Cadrenal Therapeutics, Inc. Common Stock CVKD | Armistice Capital, LLC | 93,292 9.990% | 93,292 (New Position) | Filing History |
| 2024-02-14 3:33 pm Purchase | 2023-12-31 | 13G | Cosmos Health Inc. COSM | Armistice Capital, LLC | 1,504,111 9.990% | 1,504,111 (New Position) | Filing History |
| 2024-02-14 3:32 pm Purchase | 2023-12-31 | 13G | Coeptis Therapeutics, Inc. COEP | Armistice Capital, LLC | 176,000 9.960% | 176,000 (New Position) | Filing History |
| 2024-02-14 3:32 pm Purchase | 2023-12-31 | 13G | Can-Fite BioPharma Ltd. CANF | Armistice Capital, LLC | 32,697 9.990% | 32,697 (New Position) | Filing History |
| 2024-02-14 3:31 pm Purchase | 2023-12-31 | 13G | Streamex Corp. STEX | Armistice Capital, LLC | 5,600,000 6.360% | 5,600,000 (New Position) | Filing History |
| 2024-02-14 3:31 pm Purchase | 2023-12-31 | 13G | The Beachbody Company, Inc. BODI | Armistice Capital, LLC | 401,907 9.990% | 401,907 (New Position) | Filing History |
| 2024-02-14 3:30 pm Purchase | 2023-12-31 | 13G | BIO-key International, Inc. BKYI | Armistice Capital, LLC | 121,494 9.990% | 121,494 (New Position) | Filing History |
| 2024-02-14 3:29 pm Purchase | 2023-12-31 | 13G | Bluejay Diagnostics, Inc. BJDX | Armistice Capital, LLC | 486 9.990% | 486 (New Position) | Filing History |
| 2024-02-14 3:28 pm Purchase | 2023-12-31 | 13G | Biofrontera Inc. BFRI | Armistice Capital, LLC | 168,105 9.990% | 168,105 (New Position) | Filing History |
| 2024-02-14 3:27 pm Purchase | 2023-12-31 | 13G | Aurinia Pharmaceuticals Inc. AUPH | Armistice Capital, LLC | 9,536,000 6.640% | 9,536,000 (New Position) | Filing History |